Boston Scientific TAXUS results
This article was originally published in The Gray Sheet
Executive Summary
European TAXUS IV 30-day safety data of complete study population and 12-month follow-up from 61-patient TAXUS I study presented Nov. 18 at American Heart Association meeting in Chicago. Results for the primary endpoint of cumulative major adverse cardiac events from the FilterWire EX embolic protection FIRE trial will be released later that day at the firm's evening symposium...